Single cell multi-omics analysis is being used to study heterogeneity in various types of cancer, including breast, colorectal, liver, and neuroblastoma cancers. This approach is revealing new insights into the complexity of cancer cells and has potential applications for precision drug discovery and clinical treatment. The use of multi-omics and artificial intelligence is also being explored to better understand cancer biology and improve experimental reproducibility.